Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term extension study of asenapine versus olanzapine in schizophrenia or schizoaffective disorder
2004-001376-39Phase 3Terminated
- Sponsor
- Organon & Co.
- Start
- Oct 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of asenapine and olanzapine in schizophrenia and schizoaffective disorder (2 arms), sponsored by Organon & Co. Primary endpoint: PANSS total score. Started Oct 2004; status: terminated.
02
Drugs
asenapineolanzapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on 2004-001376-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001376-39.